La. Reiter et al., TRANS-3-BENZYL-4-HYDROXY-7-CHROMANYLBENZOIC ACID-DERIVATIVES AS ANTAGONISTS OF THE LEUKOTRIENE B-4 (LTB4) RECEPTOR, Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1781-1786
The SAR of a series of 2-(7-chromanyl)benzoic acids has been investiga
ted with the aim of identifying potent and selective LTB4 receptor ant
agonists that maintain potency in complex biological fluids. We found
optimal activity in derivatives with electron-withdrawing groups in th
e benzoic acid ring and with an unsubstituted C-3 benzyl group on the
chromanol nucleus. While compounds containing a 3-(4-phenyl)benzyl chr
omanol substituent were potent LTB4 receptor antagonists, the increase
d lipophilicity imparted by the additional phenyl substituent led to d
ecreased potency in the presence of plasma proteins. From among the po
tent compounds identified, CP-195543, the 5'-trifluoromethyl 3-benzyl
chromanol, was selected for development. (C) 1998 Elsevier Science Ltd
. All rights reserved.